Improved mitochondrial function and increased oxidative phosphorylation, as seen in ovarian cancer cells with Drp1(-/17) splice variant expression, are established phenotypes of chemoresistance development in tumor cells, including ovarian cancer (Farge et al, 2017; Zampieri et al, 2020). This evidence concerns the gene DNM1L and ovarian cancer.